APC mutation	Hormone Receptor Positive Breast Cancer	APC mutation	Hormone Receptor Positive Breast Cancer	lenvatinib Resistant: C3 – Early Trials lenvatinib Resistant : C3	lenvatinib Resistant: C3 – Early Trials lenvatinib Resistant : C3
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
APC mutation	Gastrointestinal Stromal Tumor	APC mutation	Gastrointestinal Stromal Tumor	dasatinib Sensitive: C3 – Early Trials dasatinib Sensitive : C3	dasatinib Sensitive: C3 – Early Trials dasatinib Sensitive : C3
APC mutation	Colon Cancer	APC mutation	Colon Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	G007-LK Sensitive: D – Preclinical G007-LK Sensitive : D	G007-LK Sensitive: D – Preclinical G007-LK Sensitive : D
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	FL118 Sensitive: D – Preclinical FL118 Sensitive : D	FL118 Sensitive: D – Preclinical FL118 Sensitive : D
APC mutation	Colorectal Adenocarcinoma	APC mutation	Colorectal Adenocarcinoma	ST316 Sensitive: D – Preclinical ST316 Sensitive : D	ST316 Sensitive: D – Preclinical ST316 Sensitive : D
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	HMG-CoA reductase inhibitor Sensitive: D – Preclinical HMG-CoA reductase inhibitor Sensitive : D	HMG-CoA reductase inhibitor Sensitive: D – Preclinical HMG-CoA reductase inhibitor Sensitive : D
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	STP1002 Sensitive: D – Preclinical STP1002 Sensitive : D	STP1002 Sensitive: D – Preclinical STP1002 Sensitive : D

APC mutation

Associations